AbbVie to Host First-Quarter 2018 Earnings Conference Call
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Abbvie (ABBV) CL 'Buy' Rating Reiterated at Goldman Sachs Following Management Meetings; 'Sell-Off Misaligned with Fundamentals'
April 6, 2018 9:00 AM EDTGoldman Sachs maintained its price target on Abbvie (NYSE: ABBV) at $135.00 while maintaining a Conviction Buy rating, following meetings with management.
Analyst Jami Rubin reiterates the outlook and price target on the shares, despite the recent sell-off in shares (down 19.51% over the... More
